)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Sun Pharma Advanced Research Company
Sun Pharma Advanced Research Company (SPARC) investor relations material
Sun Pharma Advanced Research Company Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary9 Feb, 2026
Executive summary
Board approved unaudited standalone and consolidated financial results for Q3 and nine months ended December 31, 2025.
Financial statements reviewed by independent auditors with no material misstatements identified.
Financial highlights
Q3 consolidated revenue from operations: ₹845 lakhs, down from ₹1,491 lakhs in Q3 FY24.
Q3 consolidated net loss: ₹8,042 lakhs, compared to ₹7,951 lakhs loss in Q3 FY24.
Nine-month consolidated net loss: ₹20,814 lakhs, compared to ₹28,274 lakhs loss in the prior year period.
Basic and diluted loss per share for Q3: ₹2.48, compared to ₹2.45 in Q3 FY24.
Outlook and guidance
Company and group continue as a going concern, supported by a promoter group entity.
Monitoring ongoing regulatory changes and their financial impact.
How will the company monetize the Sezaby PRV?
What is the long-term plan for cash losses?
Explain the 9M 2025 other income of 903 Lakhs.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sun Pharma Advanced Research Company
- Oncology and immunology assets prioritized, with key cash catalysts and clinical milestones ahead.SPARC
Status Update10 Jan 2026 - Lead programs advance in oncology and immunology, backed by partnerships and cost savings.SPARCR&D Day 20268 Jan 2026
- Net loss persists amid declining revenue, with operations supported by promoter group backing.SPARCQ1 24/2521 Nov 2025
- Net loss deepened in Q2 FY25 amid falling revenues and persistent high expenses.SPARCQ2 24/2521 Nov 2025
- Losses narrowed but remain significant; promoter support continues to underpin operations.SPARCQ2 25/2610 Nov 2025
- Net loss narrowed in Q1 FY26 as revenue declined and R&D focus continued.SPARCQ1 25/264 Aug 2025
- SPARC narrowed its annual loss and plans to raise up to Rs. 1,800 crores for future growth.SPARCQ4 24/256 Jun 2025
- Q3 FY25 results reflect ongoing losses, R&D focus, and a new subsidiary for future growth.SPARCQ3 24/256 Jun 2025
Next Sun Pharma Advanced Research Company earnings date
Q4 25/2618 May, 2026
Sun Pharma Advanced Research Company
Next Sun Pharma Advanced Research Company earnings date
Q4 25/2618 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage